跳至主要内容
临床试验/CTRI/2023/08/056166
CTRI/2023/08/056166招募中2 期

A Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis inPatients with Diffuse Glioma - CHROME

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Histological diagnosis of diffuse glioma.
  • Radionecrosis on imaging with new neurological symptoms/ worsening of prior deficits (Stratum A) or
  • without new symptoms (Stratum B).
  • Karnofsky Performance Scale (KPS) = 50.

排除标准

  • No tissue diagnosis.
  • KPS < 50.
  • Disease progression
  • Contraindications to corticosteroids.
  • Altered mental status with deficits in understanding or inability to consent to the study.
  • Brainstem glioma
  • Indeterminate for radionecrosis vs disease progression
  • Prior treatment with bevacizumab (either for disease progression or radionecrosis)

研究者

相似试验